Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Acute Disseminated Encephalomyelitis Workup

  • Author: J Nicholas Brenton, MD; Chief Editor: Tarakad S Ramachandran, MBBS, MBA, MPH, FAAN, FACP, FAHA, FRCP, FRCPC, FRS, LRCP, MRCP, MRCS  more...
 
Updated: Dec 30, 2015
 

Laboratory Studies

Platelet counts are elevated in a number of children with ADEM. Sedimentation rates are elevated in a third of patients.[47]

Modest-to-moderate elevation of CSF white and red blood cell counts may be found in childhood ADEM. Red blood cells may be due to modest degrees of AHLE. Elevated CSF HSV or Lyme titers do not exclude the possibility of associated ADEM, especially in recurrent herpes encephalitis. Results of CSF immune profile testing (eg, CSF:serum immunoglobulin G [IgG] index, CNS IgG synthetic rate, oligoclonality) employing age-appropriate normative data are positive in fewer than 10% of prepubertal children with ADEM.[10]

Positivity of studies for CSF oligoclonal bands and immunoglobulin elevation favors the diagnosis of MS in individuals younger than 20 years with first or recurrent bouts of acute CNS demyelinating illness.[7] In such instances it remains incumbent on those evaluating such individuals to exclude non-MS illnesses with specific biological markers such as systemic lupus, sarcoid, neuromyelitis optica, and so forth.

CSF myelin basic protein concentration level, reflecting demyelination,[83] is frequently elevated in ADEM.

Next

Imaging Studies

The CT scan low-density abnormalities are found in more than half of childhood or adolescent ADEM cases,[47] but this technique is far less sensitive than MRI for the disclosure of extent and number of lesions.

T2-weighted and fluid attenuated inversion recovery (FLAIR), proton-density, or echo-planar trace diffusion MRI techniques disclose characteristic high-signal lesions in virtually all cases of ADEM.[47] T2/FLAIR images are particularly important in the evaluation of young individuals presenting with inflammatory CNS demyelinative illnesses that may be ADEM or MS.[11] Apparent diffusion coefficient maps show high-signal changes consistent with vasogenic edema.

ADEM lesions are characteristically multiple, bilateral but asymmetric, and widespread within the CNS.

  • Typical lesions of ADEM include centrifugal at the junction of the deep cortical gray and subcortical white matter. Such lesions are found in more than 90% of children with ADEM. They are found in less than 40% of adults initially diagnosed as having ADEM, many of whom are later diagnosed as having MS.
  • Additional lesions may be found in deeper white matter, basal ganglia (30-40%), thalamus (30-40%), brainstem (45-55%), cerebellum (30-40%), and the spinal cord (16-28%). [47, 58, 54, 11] Periventricular lesions and corpus callosal lesions are uncommon in childhood ADEM compared with MS. [11]
  • The indistinct margins of childhood ADEM lesions tend to suggest a "smudged" edge rather than the crisp margin typical of the classic ellipsoid plaques of MS.
  • Though variable, as many as 90% of childhood ADEM lesions enhance with gadolinium. The degree of contrast enhancement of ADEM lesions is typically uniform and usually not very dense. In contrast, MS plaques tend to vary in degree of contrast enhancement and may at times enhance quite densely. [12, 13, 14]
    Typical childhood ADEM in 7-year-old. Note tendenc Typical childhood ADEM in 7-year-old. Note tendency to involve gray-white junction, the fact that the lesion margins are less well defined than typical MS plaques, and that the deep white matter lesions are not oriented perpendicularly to the ventricular surface as is typical in MS.
    Typical adolescent multiple sclerosis findings on Typical adolescent multiple sclerosis findings on MRI. Note the tendency of lesions to exhibit sharp margins, to be elongated, to occur in deep white matter or corpus callosum sparing the cortical gray-white junction, and to be oriented perpendicularly to the ventricular surface.
  • Many of the diseases that constitute the differential diagnosis of ADEM produce MRI abnormalities that emulate various ADEM-associated lesions.
    • Some cases of encephalitis result in the development of multiple tiny or small patches of bright signal on T2-weighted images that have been mislabeled as ADEM, but response to corticosteroid therapy is poor and follow-up scans may show severe encephalomalacia.
    • HSV-2 encephalitis or Lyme disease may be difficult to distinguish from ADEM and may involve ADEM mechanisms in pathogenesis.
    • Pial enhancement does not occur in ADEM and suggests meningoencephalitis.
    • Metazoal parasitic diseases of the brain (eg, cysticercosis), neoplasia, and ADEM are occasionally mistaken for one another.
    • Metabolic leukdystrophies may appear similar on MRI but often exhibit symmetric abnormalities in the white matter (as opposed to the asymmetric abnormalities seen in ADEM).
  • ADEM lesions may contain areas of hemorrhage suggestive of HSV-2 encephalitis, changes never found in MS plaques.
  • Unusual MRI abnormalities that are found in young individuals suspected of having ADEM may help greatly in distinguishing ADEM from MS or other alternative diagnoses. ADEM gives rise to a much wider variety of appearances than MS. ADEM may produce large unilateral T2 bright lesions, some of which appear to have striking central cavitation. These lesions may suggest neoplasm, stroke, parasitism, abscess, or MS. Ring enhancement or mass effect sometimes found in ADEM may suggest abscess or tumor. [15] In rare cases, symmetrical, linear, posteriorly emphasized white matter changes on T2 weighting suggest leukodystrophy. Recognize that no changes on MRI are pathognomonic of ADEM or, for that matter, of demyelination.
  • Some patients with ADEM have normal findings on MRI on initial presentation that become abnormal and characteristic of ADEM if the study is repeated several weeks later. [16] This suggests that characteristic features may be missed because of sampling error, that normal findings on a scan do not exclude the ADEM diagnosis, and that the appearance of new lesions during the course of ADEM may not represent recrudescence of disease.

Magnetization transfer MRI, single photon emission CT scanning, or nuclear magnetic resonance (NMR) spectroscopy may possibly prove helpful in distinguishing ADEM from alternative diagnoses, although the development of a pathognomonic imaging result is unlikely. For these reasons, diagnosing ADEM on the basis of findings on scanning alone is dangerous. Diagnosis of ADEM should always rest on clinical grounds in children as in adults.

  • Radiographic studies and other laboratory tests are especially valuable in ruling in or out alternative diagnoses.

From a retrospective analysis, Callen et al propose diagnostic criteria for MRI to distinguish a first MS attack in children from those with acute disseminated encephalomyelitis. Any 2 of the following criteria could distinguish MS from acute disseminated encephalomyelitis (sensitivity 81%, specificity 95%): (1) absence of a diffuse bilateral lesion pattern, (2) presence of black holes, and (3) presence of 2 or more periventricular lesions.[11]

Previous
Next

Other Tests

See the list below:

  • The EEG often exhibits a disturbance of normal sleep rhythms and focal or generalized slowing. Epileptiform discharges are rarely seen in ADEM. [47] The absence of such abnormalities during the first bout of acute disseminated demyelinating illness in a child may increase the suspicion for ultimate MS diagnosis. Similar EEG abnormalities are found in adult ADEM. [84]
  • Visual evoked potentials (VEP) may prove helpful when optic neuritis is suspected but not apparent on clinical examination.
Previous
Next

Procedures

The lumbar puncture is an essential aspect of acute disseminated encephalomyelitis (ADEM) workup.[17] It assists in distinguishing ADEM from various forms of meningoencephalitis, especially upon the basis of titers for the various bacteria, viruses, or other agents that may produce a directly infectious form of meningoencephalitis.

  • The immune profile is also helpful in distinguishing ADEM from MS. The IgG index, IgG synthetic rate, or oligoclonal bands are positive in more than two thirds of all first clinically recognized MS bouts and in 90-98% of individuals who have experienced multiple MS bouts. One or more of these studies is positive in a minority of ADEM cases.
  • Note that the findings on immune profile studies may be positive in various infectious conditions such as neurosyphilis, subacute sclerosing panencephalitis (SSPE), Lyme disease, stroke, and various forms of acute or chronic bacterial or viral meningoencephalitis. The CSF:serum IgG index or synthetic rate formulations may show positive results in neurosyphilis, Lyme disease, Guillain-Barré syndrome, some brain tumors, sarcoid, and a wide variety of bacterial or viral meningoencephalitides or other forms of CNS inflammation.

Occasionally, brain biopsy is necessary to distinguish ADEM from other diagnostic possibilities. The diagnosis of ADEM is confirmed when typical perivenular demyelinating changes with axonal sparing are observed.[47, 85]

Previous
 
 
Contributor Information and Disclosures
Author

J Nicholas Brenton, MD Assistant Professor of Pediatrics and Neurology, University of Virginia School of Medicine

J Nicholas Brenton, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, Child Neurology Society

Disclosure: Nothing to disclose.

Coauthor(s)

Robert Stanley Rust, Jr, MD, MA Thomas E Worrell Jr Professor of Epileptology and Neurology, Co-Director of FE Dreifuss Child Neurology and Epilepsy Clinics, Director, Child Neurology, University of Virginia School of Medicine; Chair-Elect, Child Neurology Section, American Academy of Neurology

Robert Stanley Rust, Jr, MD, MA is a member of the following medical societies: Child Neurology Society, Society for Pediatric Research, American Headache Society, International Child Neurology Association, American Academy of Neurology, American Epilepsy Society, American Neurological Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Glenn Lopate, MD Associate Professor, Department of Neurology, Division of Neuromuscular Diseases, Washington University School of Medicine; Consulting Staff, Department of Neurology, Barnes-Jewish Hospital

Glenn Lopate, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, Phi Beta Kappa

Disclosure: Nothing to disclose.

Chief Editor

Tarakad S Ramachandran, MBBS, MBA, MPH, FAAN, FACP, FAHA, FRCP, FRCPC, FRS, LRCP, MRCP, MRCS Professor Emeritus of Neurology and Psychiatry, Clinical Professor of Medicine, Clinical Professor of Family Medicine, Clinical Professor of Neurosurgery, State University of New York Upstate Medical University; Neuroscience Director, Department of Neurology, Crouse Irving Memorial Hospital

Tarakad S Ramachandran, MBBS, MBA, MPH, FAAN, FACP, FAHA, FRCP, FRCPC, FRS, LRCP, MRCP, MRCS is a member of the following medical societies: American College of International Physicians, American Heart Association, American Stroke Association, American Academy of Neurology, American Academy of Pain Medicine, American College of Forensic Examiners Institute, National Association of Managed Care Physicians, American College of Physicians, Royal College of Physicians, Royal College of Physicians and Surgeons of Canada, Royal College of Surgeons of England, Royal Society of Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Christopher Luzzio, MD Clinical Assistant Professor, Department of Neurology, University of Wisconsin at Madison School of Medicine and Public Health

Christopher Luzzio, MD is a member of the following medical societies: American Academy of Neurology

Disclosure: Nothing to disclose.

References
  1. Alper G. Acute disseminated encephalomyelitis. J Child Neurol. 2012 Nov. 27(11):1408-25. [Medline].

  2. Huppke P, Rostasy K, Karenfort M, Huppke B, Seidl R, Leiz S, et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler. 2012 Nov 5. [Medline].

  3. Ishizu T, Minohara M, Ichiyama T, et al. CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. J Neuroimmunol. 2006 Jun. 175(1-2):52-8. [Medline].

  4. Franciotta D, Zardini E, Ravaglia S, et al. Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. J Neurol Sci. 2006 Sep 25. 247(2):202-7. [Medline].

  5. Banwell B, Kennedy J, Sadovnick D, Arnold DL, Magalhaes S, Wambera K, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology. 2009 Jan 20. 72(3):232-9. [Medline].

  6. Sacconi S, Salviati L, Merelli E. Acute disseminated encephalomyelitis associated with hepatitis C virus infection. Arch Neurol. 2001 Oct. 58(10):1679-81. [Medline].

  7. Alper G, Heyman R, Wang L. Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: comparison of presenting features. Dev Med Child Neurol. 2009 Jun. 51(6):480-6. [Medline]. [Full Text].

  8. Chowdhary J, Ashraf SM, Khajuria K. Measles with acute disseminated encephalomyelitis (ADEM). Indian Pediatr. 2009 Jan. 46(1):72-4. [Medline].

  9. Alves-Leon SV, Veluttini-Pimentel ML, Gouveia ME, Malfetano FR, Gaspareto EL, Alvarenga MP, et al. Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study. Arq Neuropsiquiatr. 2009 Sep. 67(3A):643-51. [Medline].

  10. Rust RS, Dodson WE, Trotter JL. Cerebrospinal fluid IgG in childhood: the establishment of reference values. Ann Neurol. 1988 Apr. 23(4):406-10. [Medline].

  11. Callen DJ, Shroff MM, Branson HM, Li DK, Lotze T, Stephens D, et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology. 2009 Mar 17. 72(11):968-73. [Medline].

  12. Baum PA, Barkovich AJ, Koch TK, Berg BO. Deep gray matter involvement in children with acute disseminated encephalomyelitis. AJNR Am J Neuroradiol. 1994 Aug. 15(7):1275-83. [Medline].

  13. Apak RA, Kose G, Anlar B, et al. Acute disseminated encephalomyelitis in childhood: report of 10 cases. J Child Neurol. 1999 Mar. 14(3):198-201. [Medline].

  14. Kesselring J, Miller DH, Robb SA, Kendall BE, Moseley IF, Kingsley D, et al. Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain. 1990 Apr. 113 ( Pt 2):291-302. [Medline].

  15. van der Meyden CH, de Villiers JF, Middlecote BD, Terblanchè J. Gadolinium ring enhancement and mass effect in acute disseminated encephalomyelitis. Neuroradiology. 1994 Apr. 36(3):221-3. [Medline].

  16. Honkaniemi J, Dastidar P, Kähärä V, Haapasalo H. Delayed MR imaging changes in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol. 2001 Jun-Jul. 22(6):1117-24. [Medline].

  17. Trotter JL, Rust RS. Human cerebrospinal fluid immunology. In: Herndon RM, Brumback RA, eds. The Cerebrospinal Fluid. Boston, Mass:. Kluwer Academic Publishers. 1989:179-226.

  18. Nishikawa M, Ichiyama T, Hayashi T, Ouchi K, Furukawa S. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol. 1999 Aug. 21(2):583-6. [Medline].

  19. Stricker RB, Miller RG, Kiprov DD. Role of plasmapheresis in acute disseminated (postinfectious) encephalomyelitis. J Clin Apher. 1992. 7(4):173-9. [Medline].

  20. Kanter DS, Horensky D, Sperling RA, Kaplan JD, Malachowski ME, Churchill WH Jr. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology. 1995 Apr. 45(4):824-7. [Medline].

  21. Sugita K, Suzuki N, Shimizu N, Takanashi J, Ishii M, Niimi N. Involvement of cytokines in N-methyl-N'-nitro-N-nitrosoguanidine-induced plasminogen activator activity in acute disseminated encephalomyelitis and multiple sclerosis lymphocytes. Eur Neurol. 1993. 33(5):358-62. [Medline].

  22. Kuni BJ, Banwell BL, Till C. Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM). Dev Neuropsychol. 2012 Nov. 37(8):682-96. [Medline].

  23. Atalar MH. Acute disseminated encephalomyelitis in an adult patient. Magnetic resonance and diffusion-weighted imaging findings. Saudi Med J. 2006 Jan. 27(1):105-8. [Medline].

  24. Brinar VV. Non-MS recurrent demyelinating illnesses. Clin Neurol Neurosurg. 2004. 106(3):197-210.

  25. Dale RC, Branson JA. Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis?. Arch Dis Child. 2005 Jun. 90(6):636-9. [Medline].

  26. Garg RK. Acute disseminated encephalomyelitis. Postgrad Med J. 2003 Jan. 79(927):11-7. [Medline].

  27. Hahn JS, Siegler DJ, Enzmann D. Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology. 1996 Apr. 46(4):1173-4. [Medline].

  28. Hartel C, Schilling S, Gottschalk S, Sperner J. Multiphasic disseminated encephalomyelitis associated with streptococcal infection. Eur J Paediatr Neurol. 2002. 6(6):327-9. [Medline].

  29. Holtmannspotter M, Inglese M, Rovaris M, et al. A diffusion tensor MRI study of basal ganglia from patients with ADEM. J Neurol Sci. 2003 Jan 15. 206(1):27-30. [Medline].

  30. John L, Khaleeli AA, Larner AJ. Acute disseminated encephalomyelitis: a riddle wrapped in a mystery inside an enigma. Int J Clin Pract. 2003 Apr. 57(3):235-7. [Medline].

  31. Kadhim H, De Prez C, Gazagnes MD, Sebire G. In situ cytokine immune responses in acute disseminated encephalomyelitis: insights into pathophysiologic mechanisms. Hum Pathol. 2003 Mar. 34(3):293-7. [Medline].

  32. Mariotti P, Batocchi AP, Colosimo C,et al. Multiphasic demyelinating disease involving central and peripheral nervous system in a child. Neurology. 2003 Jan 28. 60(2):348-9. [Medline].

  33. Murthy JM. Acute disseminated encephalomyelitis. Neurol India. 2002 Sep. 50(3):238-43. [Medline].

  34. Oksuzler YF, Cakmakci H, Kurul S, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging in pediatric cerebral diseases. Pediatr Neurol. 2005 May. 32(5):325-33. [Medline].

  35. Pena JA, Montiel-Nava C, Hernandez F, et al. [Disseminated acute encephalomyelitis in children]. Rev Neurol. 2002 Jan 16-31. 34(2):163-8. [Medline].

  36. Pradhan S, Gupta RP, Shashank S, Pandey N. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci. 1999 May 1. 165(1):56-61. [Medline].

  37. Rust RS. Multiple sclerosis, acute disseminated encephalomyelitis, and related conditions. Semin Pediatr Neurol. 2000 Jun. 7(2):66-90. [Medline].

  38. Sakakibara R, Yamanishi T, Uchiyama T, Hattori T. Acute urinary retention due to benign inflammatory nervous diseases. J Neurol. 2006 Aug. 253(8):1103-10. [Medline].

  39. Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology. 2001 May 22. 56(10):1313-8. [Medline].

  40. Sunnerhagen KS, Johansson K, Ekholm S. Rehabilitation problems after acute disseminated encephalomyelitis: four cases. J Rehabil Med. 2003 Jan. 35(1):20-5. [Medline].

  41. Tenembaum S, Chamoles N. Acute disseminated encephalomyelitis: a longterm follow-up study of 84 pediatric patients. J Neurol Neurosurg Psychiatr. 1995. 58(4):467-470.

  42. Verbruggen SC, Catsman CE, Naghib S, et al. [Respiratory insufficiency caused by acute disseminated encephalomyelitis in a child]. Ned Tijdschr Geneeskd. 2006 May 20. 150(20):1134-8. [Medline].

  43. Weng WC, Peng SS, Lee WT, et al. Acute disseminated encephalomyelitis in children: one medical center experience. Acta Paediatr Taiwan. 2006 Mar-Apr. 47(2):67-71. [Medline].

  44. Wingerchuk DM. The clinical course of acute disseminated encephalomyelitis. Neurol Res. 2006 Apr. 28(3):341-7. [Medline].

  45. Yapici Z, Eraksoy M. Bilateral demyelinating tumefactive lesions in three children with hemiparesis. J Child Neurol. 2002 Sep. 17(9):655-60. [Medline].

  46. Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology. 2007. 68(suppl 2):S23-S36. [Full Text].

  47. Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain. 2000 Dec. 123 Pt 12:2407-22. [Medline].

  48. Dale RC. Acute disseminated encephalomyelitis. Semin Pediatr Infect Dis. 2003 Apr. 14(2):90-5. [Medline].

  49. Van Haren K, Tomooka BH, Kidd BA, Banwell B, Bar-Or A, Chitnis T. Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis. Mult Scler. 2013 Nov. 19(13):1726-33. [Medline].

  50. Baumann M, Sahin K, Lechner C, Hennes EM, Schanda K, Mader S. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry. 2014 Aug 13. [Medline].

  51. Pröbstel AK, Dornmair K, Bittner R, Sperl P, Jenne D, Magalhaes S. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology. 2011 Aug 9. 77(6):580-8. [Medline].

  52. Brilot F, Dale RC, Selter RC, Grummel V, Kalluri SR, Aslam M, et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol. 2009 Dec. 66(6):833-42. [Medline].

  53. Di Pauli F, Mader S, Rostasy K, Schanda K, Bajer-Kornek B, Ehling R. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol. 2011 Mar. 138(3):247-54. [Medline].

  54. Murthy SN, Faden HS, Cohen ME, Bakshi R. Acute disseminated encephalomyelitis in children. Pediatrics. 2002 Aug. 110(2 Pt 1):e21. [Medline].

  55. Leake JA, Albani S, Kao AS, Senac MO, Billman GF, Nespeca MP, et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J. 2004 Aug. 23(8):756-64. [Medline].

  56. Pohl D, Hennemuth I, von Kries R, Hanefeld F. Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey. Eur J Pediatr. 2007 May. 166(5):405-12. [Medline].

  57. Torisu H, Kira R, Ishizaki Y, Sanefuji M, Yamaguchi Y, Yasumoto S. Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev. 2010 Jun. 32(6):454-62. [Medline].

  58. Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology. 2001 May 22. 56(10):1308-12. [Medline].

  59. Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013 Sep. 19(10):1261-7. [Medline].

  60. Hung KL, Liao HT, Tsai ML. The spectrum of postinfectious encephalomyelitis. Brain Dev. 2001 Mar. 23(1):42-5. [Medline].

  61. Mikaeloff Y, Suissa S, Vallée L, Lubetzki C, Ponsot G, Confavreux C, et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr. 2004 Feb. 144(2):246-52. [Medline].

  62. Idrissova ZhR, Boldyreva MN, Dekonenko EP, Malishev NA, Leontyeva IY, Martinenko IN, et al. Acute disseminated encephalomyelitis in children: clinical features and HLA-DR linkage. Eur J Neurol. 2003 Sep. 10(5):537-46. [Medline].

  63. Anlar B, Basaran C, Kose G, Guven A, Haspolat S, Yakut A, et al. Acute disseminated encephalomyelitis in children: outcome and prognosis. Neuropediatrics. 2003 Aug. 34(4):194-9. [Medline].

  64. Jacobs RK, Anderson VA, Neale JL, Shield LK, Kornberg AJ. Neuropsychological outcome after acute disseminated encephalomyelitis: impact of age at illness onset. Pediatr Neurol. 2004 Sep. 31(3):191-7. [Medline].

  65. Hahn CD, Miles BS, MacGregor DL, Blaser SI, Banwell BL, Hetherington CR. Neurocognitive outcome after acute disseminated encephalomyelitis. Pediatr Neurol. 2003 Aug. 29(2):117-23. [Medline].

  66. Brenton JN, Koenig S, Goldman MD. Vitamin D status and age of onset of demyelinating disease. Multiple Sclerosis and Related Disorders. 2014. [Full Text].

  67. Mowry EM, James JA, Krupp LB, Waubant E. Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis. Mult Scler. 2011 Jun. 17(6):666-71. [Medline].

  68. Banwell B, Bar-Or A, Arnold DL, Sadovnick D, Narayanan S, McGowan M. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol. 2011 May. 10(5):436-45. [Medline].

  69. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 Dec 20. 296(23):2832-8. [Medline].

  70. Mikaeloff Y, Caridade G, Husson B, Suissa S, Tardieu M. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol. 2007 Mar. 11(2):90-5. [Medline].

  71. McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, et al. CNS aquaporin-4 autoimmunity in children. Neurology. 2008 Jul 8. 71(2):93-100. [Medline].

  72. Saiki S, Ueno Y, Moritani T, Sato T, Sekine T, Kawajiri S. Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica. J Neurol Sci. 2009 Sep 15. 284(1-2):217-9. [Medline].

  73. Eichel R, Meiner Z, Abramsky O, Gotkine M. Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates. Arch Neurol. 2008 Feb. 65(2):267-71. [Medline].

  74. Kaneko K, Sato DK, Misu T, Kurosawa K, Nakashima I, Fujihara K. Anti-N-methyl-D-aspartate receptor encephalitis with multiphasic demyelination. Ann Neurol. 2014 Sep. 76(3):462-4. [Medline].

  75. Okumura A, Nakazawa M, Igarashi A, Abe S, Ikeno M, Nakahara E, et al. Anti-aquaporin 4 antibody-positive acute disseminated encephalomyelitis. Brain Dev. 2014 May 16. [Medline].

  76. Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, et al. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014 Mar. 75(3):411-28. [Medline]. [Full Text].

  77. Huppke P, Rostasy K, Karenfort M, Huppke B, Seidl R, Leiz S, et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler. 2013 Jun. 19(7):941-6. [Medline].

  78. Shaw CM, Alvord EC Jr. Multiple sclerosis beginning in infancy. J Child Neurol. 1987 Oct. 2(4):252-6. [Medline].

  79. Maeda Y, Kitamoto I, Kurokawa T, Ueda K, Hasuo K, Fujioka K. Infantile multiple sclerosis with extensive white matter lesions. Pediatr Neurol. 1989 Sep-Oct. 5(5):317-9. [Medline].

  80. Vliegenthart WE, Sanders EA, Bruyn GW, Vielvoye GJ. An unusual CT-scan appearance in multiple sclerosis. J Neurol Sci. 1985 Nov. 71(1):129-34. [Medline].

  81. Noorbakhsh F, Johnson RT, Emery D, Power C. Acute disseminated encephalomyelitis: clinical and pathogenesis features. Neurol Clin. 2008 Aug. 26(3):759-80, ix. [Medline].

  82. Cohen SR, Brooks BR, Herndon RM, McKhann GM. A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid. Ann Neurol. 1980 Jul. 8(1):25-31. [Medline].

  83. Höllinger P, Sturzenegger M, Mathis J, Schroth G, Hess CW. Acute disseminated encephalomyelitis in adults: a reappraisal of clinical, CSF, EEG, and MRI findings. J Neurol. 2002 Mar. 249(3):320-9. [Medline].

  84. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology. 2002 Oct 22. 59(8):1224-31. [Medline].

  85. Kleiman M, Brunquell P. Acute disseminated encephalomyelitis: response to intravenous immunoglobulin. J Child Neurol. 1995 Nov. 10(6):481-3. [Medline].

  86. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002 Jan 8. 58(1):143-6. [Medline].

  87. Rust RS, Mathisen J, Prensky AL, et al. Acute disseminatedencephalomyelitis (ADE) and childhood multiple sclerosis(MS). Ann Neurol. 1989. 26:467.

 
Previous
Next
 
Fatal ADEM-related transverse myelitis in a 13-month-old. This is an image of the MIDBRAIN NOT OF THE CERVICAL CORD RECOMMEND ELIMINATING THIS and ADD AN IMAGE OF THE CERVICAL CORD AFFECTED BY ADEM-RELATED TANSVERSE MYELITIS
Typical childhood ADEM in 7-year-old. Note tendency to involve gray-white junction, the fact that the lesion margins are less well defined than typical MS plaques, and that the deep white matter lesions are not oriented perpendicularly to the ventricular surface as is typical in MS.
Typical adolescent multiple sclerosis findings on MRI. Note the tendency of lesions to exhibit sharp margins, to be elongated, to occur in deep white matter or corpus callosum sparing the cortical gray-white junction, and to be oriented perpendicularly to the ventricular surface.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.